Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Intangibles (2016 - 2026)

Neuroone Medical Technologies filings provide 9 years of Intangibles readings, the most recent being $33789.0 for Q1 2026.

  • On a quarterly basis, Intangibles fell 39.77% to $33789.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $33789.0, a 39.77% decrease, with the full-year FY2025 number at $44946.0, down 33.18% from a year prior.
  • Intangibles hit $33789.0 in Q1 2026 for Neuroone Medical Technologies, down from $39368.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $123049.0 in Q1 2022 to a low of $33789.0 in Q1 2026.
  • Median Intangibles over the past 5 years was $78419.0 (2024), compared with a mean of $78419.2.
  • Biggest five-year swings in Intangibles: fell 15.35% in 2022 and later tumbled 39.77% in 2026.
  • Neuroone Medical Technologies' Intangibles stood at $106313.0 in 2022, then fell by 20.99% to $83998.0 in 2023, then fell by 26.57% to $61683.0 in 2024, then plummeted by 36.18% to $39368.0 in 2025, then fell by 14.17% to $33789.0 in 2026.
  • The last three reported values for Intangibles were $33789.0 (Q1 2026), $39368.0 (Q4 2025), and $44946.0 (Q3 2025) per Business Quant data.